Ceftazidime tobramycin fixed drug combination (FDC) versus ceftazidime in lower respiratory tract infections

INTERVENTION: 1. Ceftazidime (1 g) and tobramycin (120 mg) fixed drug combination (FDC), eight‐hourly, intravenous (i.v.) for seven days 2. Ceftazidime (1 g), eight‐hourly, i.v. for seven days CONDITION: Lower respiratory tract infections ; Infections and Infestations ; Lower respiratory tract infections PRIMARY OUTCOME: Improvement in clinical and laboratory parameters, measured on day 0 and day 7, followed up to 10 days after the treatment. SECONDARY OUTCOME: To observe incidence of adverse events as assessed by clinical evaluation and laboratory parameters, measured on day 0 and day 7, followed up to 10 days after the treatment. INCLUSION CRITERIA: 1. Participants aged greater than 18 years (n = 240), either sex 2. Hopsitalised patients suffering from lower respiratory tract infections